We are live on ! Find out more
AIIC

AJU IB Investment Company Portfolio holdings

AUM $30.5M
1-Year Est. Return 128.96%
This Fund
S&P 500
This Quarter Est. Return
-29.88%
1 Year Est. Return
+128.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$64.8M
AUM Growth
-$7.02M
Cap. Flow
+$23.1M
Cap. Flow %
35.65%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$23.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$19.4M 29.89%
+1,380,890
New +$23.1M
KYMR icon
2
Kymera Therapeutics
KYMR
$8.95B
$19.3M 29.87%
457,059
SEER icon
3
Seer Inc
SEER
$120M
$12.4M 19.21%
816,375
RLYB icon
4
Rallybio
RLYB
$87.7M
$5.27M 8.13%
94,335
XLO icon
5
Xilio Therapeutics
XLO
$59.2M
$4.72M 7.29%
47,696
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
$2.19M 3.38%
12,438
STRO icon
7
Sutro Biopharma
STRO
$432M
$1.44M 2.22%
17,500

Similar funds

AJU IB Investment Company's Q1 2022 Portfolio in Review

As of Q1 2022, AJU IB Investment Company held 7 positions worth $64.8M, down 9.8% from $71.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AJU IB Investment Company deployed $23.1M of net new capital in Q1 2022, opening 1 new position. Its largest new stake was Arcellx: 1,380,890 shares worth $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AJU IB Investment Company's largest Q1 2022 buy was Arcellx: 1,380,890 shares worth $19.4M.
  • AJU IB Investment Company's ten largest holdings make up 100% of its $64.8M portfolio in Q1 2022.
  • AJU IB Investment Company opened 1 new position and closed 0 in Q1 2022.
  • AJU IB Investment Company's portfolio value fell 9.8% quarter-over-quarter to $64.8M.

Based on AJU IB Investment Company's 13F filing for Q1 2022, filed 12 May 2022.